2024 perioperative management glp-1 receptor agonists anesthesia of patients taking glucagon-like peptide 1 agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement Perioperative Management of GLP-1 Receptor

So when someone says, GLP-1s cause muscle loss, the first question should be: what exactly was measured

As global demand rises for effective metabolic therapies, GLP-1 drug development remains one of the fastest-growing segments in biopharma innovation

Semaglutide: Tirzepatide is a dual agonist for GLP-1 and GIP receptors

GLP-1 drugs like Ozempic have transformed weight management, but concerns around muscle loss, bone density, dampened desire, and dependency are growing

Explore how nutrition can support natural GLP-1 production, a hormone key to blood sugar regulation and weight management, often targeted by popular weight loss medications

Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors